by Tim Bolen
Bolen Report

There was a day in Texas when sleaze artist Stephen Barrett could call up the Executive Director of the Texas Medical Board and “arrange” a prosecution of a Texas cutting-edge doctor, even offering his even sleazier “skeptic” companion, Bobbie Baratz, as the do-all, be-all, expert witness against that doctor. Those days are over. The Texas Medical Board is on a short leash, after an assault by the Texas legislature, at the request of components of the the U.S. Health Freedom Movement.

As you can see below, from an excerpt of an email sent to me by Burzynski’s attorney, Rick Jaffe, the Board decided it had other things to do, rather than continue to be mauled by Burzynski’s network. See below:

Stan Burzynski’s Four Year Battle with the Texas Medical Board Ends. Case Dismissed!

On November 19, 2012, judges of the Texas State Office of Administrative Hearings dismissed the Texas Medical Board’s pending case against Dr. Burzynski. The investigation started by the board in 2008 involved Burzynski’s novel off-label use of combination gene targeted therapy. Early on, two medical board informal settlement panels found that the use of these combination drugs on the advanced cancer patients involved was within the standard of care. However, the Texas Medical Board refused to drop the case and instead filed a formal complaint against Dr. Burzynski, alleging the same standard of care violations previously rejected by the board settlement panels. After two years of intense litigation, the case was set for trial in April, 2012. However, a week before trial, the administrative law judges dismissed most of the charges against Dr. Burzynski, which forced the Board to seek to adjourn the case to do some reevaluation. After the judges denied the Board’s attempt to reverse the previous partial dismissal of the case, the Board did more reevaluation and moved to dismiss the entire case. We didn’t oppose the motion, and on November 19, 2012, the case was dismissed.

The cutting-edge, multi-agent gene targeted therapy devised by Dr. Burzynski, which was at the heart of this proceeding, is still being given at the clinic and is helping countless patients. The Burzynski Clinic thanks all of its supporters and wishes all a Happy Thanksgiving and thanks. – Rick.

Click here to see a copy of the Order.

According to Burzynski’s lawyer Rick Jaffe, “I’m glad we didn’t have to spend three weeks on a trial. It would have been a complete waste of time and money.”

Jaffe also says that, “Things are a little better in Texas now that the Texas Medical Board has been stripped of its power to summarily overturn decisions by the independent state office of administrative hearings. I’d like to see that happen in more states. Sometimes the judges are reasonable, but the boards have a bias against CAM practitioners, and in most of the states I litigate in, they can do what they want.”

The Amusing Part…

Burzynski’s victory, I think, will be particularly galling to the “skeptic” movement who had organized an Internet “hate” campaign against Burzynski, clearly attempting to destroy him and his reputation. Despite their best efforts, that, obviously, has failed.

More, the “skeptic” campaign to stop Burzynski’s FDA approved Clinical Trials of his therapies, has failed just as miserably.

Burzynski: Cancer Is Serious Business

Read the full article here: http://www.bolenreport.com/feature_articles/Burzynski%20Batters%20Texas%20Medical%20Board.htm

We Lost the War on Cancer – Review of Alternative Cancer Therapies

eBook
Retail : $9⁹⁹
Now : $5⁹⁹

We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.

The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.

The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink.

John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it in Part I. In Part II, he surveys the various alternative cancer therapies that have been proven effective, but that are not approved by the FDA.